Comparison of Pharmacokinetic (PK) and Pharmacodynamic(PD) of Biocon Insulin 70/30 and Humulin® 70/30

NCT04022291 PHASE1 COMPLETED

Two-centre, randomised, double-blind, single dose, two-treatment, two-period, two sequence, crossover, 24-hour euglycaemic glucose clamp trial in healthy subjects.

Details

Lead sponsor	Biocon Limited
Phase	PHASE1
Status	COMPLETED
Enrolment	78
Start date	Sat Jun 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Jan 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Healthy Volunteer

Interventions

• Humulin ®70/30
• Biocon Insulin 70/30

Countries

Germany